Foot and Mouth Disease Vaccines Market by Product and Geography - Forecast and Analysis 2021-2025

The foot and mouth disease vaccines market share is expected to increase by USD 1.08 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 8.81%.

This foot and mouth disease vaccines market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers foot and mouth disease vaccines market segmentations by product (conventional vaccines and emergency vaccines) and geography (Asia, Europe, North America, and ROW). The foot and mouth disease vaccines market report also offers information on several market vendors, including Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Indian Immunologicals Ltd., Inovio Pharmaceuticals Inc., LIMOR DE COLOMBIA SA , Merck & Co. Inc., SEPPIC SA, VECOL SA, and VETAL Animal Health Products Inc. among others.

What will the Foot And Mouth Disease Vaccines Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Foot and Mouth Disease Vaccines Market Size for the Forecast Period and Other Important Statistics

 

Foot And Mouth Disease Vaccines Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The increase in government initiatives is notably driving the foot and mouth disease vaccines market growth, although factors such as increase in vaccine failures may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the foot and mouth disease vaccines industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Foot And Mouth Disease Vaccines Market Driver

The increase in government initiatives is notably driving the foot and mouth disease vaccine market growth. The increase in government initiatives is expected to propel market growth. Government across various FMD endemic countries has been continuously pursuing plans to eradicate FMD by conducting various programs. It is also providing funds to foster R&D activities in the market. For the Foot and Mouth Disease Control Program, the government allocated $22.7 million in funding. This program will be implemented in 351 districts in India. Funds under this program will be provided for the procurement of FMD vaccines for various purposes, including meeting vaccination costs, animal identification cards, and other logistical support. Moreover, the US Congress passed a Farm Bill in December 2018 that sets aside money for an animal vaccine bank with an emphasis on FMD vaccines. Such initiatives by the government as well as other agencies will help boost R&D activities, thereby driving growth in the market.

Key Foot And Mouth Disease Vaccines Market Trend

An increase in inorganic growth strategies is the key market trend driving the foot and mouth disease vaccine market growth. The market has been witnessing a trend of increased mergers and acquisitions, which will likely drive market growth. Vendors are increasingly focusing on inorganic growth strategies to expand their presence and expertise in the market. In addition, such strategies will boost their growth and profitability in the market. These strategies will be beneficial for new companies that aim to penetrate the market quickly. These are among the leading animal health companies in the world. The acquisition will enable Ceva to expand its portfolio of animal health products, including the FMD vaccine from Inova Biotecnologia. The vendors are also forming collaborations to expand their reach in the market. Such initiatives will likely fuel market growth.

Key Foot And Mouth Disease Vaccines Market Challenge

An increase in vaccine failures is the major challenge impeding the foot and mouth disease vaccine market growth. There have been reports of vaccine failures regarding safety and efficacy in the prevention and treatment of FMD. This is expected to hinder the growth prospects, particularly in the developing world. The alleged vaccine failures may also pose a threat to animals in Europe and North America. FMD vaccine testing report (a research study of the Indian Council of Agricultural Research) stated that vaccine samples taken from Indian Immunologicals, Intervet India, and Brilliant BioPharma had no desired emulsion stability and failed in sterility tests to meet the standards and ethics of vaccine production. This indicates that the recent FMD outbreaks in India were due to the poor quality of vaccines resulting in huge economic losses. Such issues would hamper the market growth.

This foot and mouth disease vaccines market analysis report also provide detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categorizes the global foot and mouth disease vaccines market as a part of the pharmaceutical market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the foot and mouth disease vaccines market during the forecast period.

Who are the Major Foot And Mouth Disease Vaccines Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

• Biogenesis Bago SA
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Indian Immunologicals Ltd.
• Inovio Pharmaceuticals Inc.
• LIMOR DE COLOMBIA SA 
• Merck & Co. Inc.
• SEPPIC SA
• VECOL SA
• VETAL Animal Health Products Inc.

 

This statistical study of the foot and mouth disease vaccines market encompasses successful business strategies deployed by the key vendors. The foot and mouth disease vaccines market is concentrated and the vendors are deploying growth strategies such as adopting new technologies and new product offerings to compete in the market.

Product Insights and News

• VECOL SA - The company offers products such as Diprina, Kenogan, and other products.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The foot and mouth disease vaccines market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Foot And Mouth Disease Vaccines Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the foot and mouth disease vaccines market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Foot And Mouth Disease Vaccines Market?

For more insights on the market share of various regions Request for a FREE sample now!

63% of the market's growth will originate from Asia during the forecast period. China, South Korea (Republic of Korea), and India are the key markets for the foot and mouth disease vaccines market in Asia. Market growth in this region will be faster than the growth of the European and North American markets.

The widespread awareness programs undertaken by governments, vendors, and non-government public entities will facilitate the foot and mouth disease vaccines market growth in Asia over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

Factors such as the severe shortage of foot and mouth disease vaccines in most developing countries, the lack of awareness about veterinary facilities, and the inaccessibility to treatment are expected to negatively impact the growth of the foot and mouth disease vaccines market in the region. Also, due to the outbreak of COVID-19 in 2020, operations in manufacturing facilities were temporarily halted in countries such as China and Japan in early 2020, which impacted the growth of the foot and mouth disease vaccines market in the region. However, the development and distribution of vaccines for COVID-19 from the beginning of 2021 and the lifting of restrictive measures will aid the growth of the market in the region during the forecast period.

What are the Revenue-generating Product Segments in the Foot And Mouth Disease Vaccines Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The foot and mouth disease vaccines market share growth by the conventional vaccines segment will be significant during the forecast period. The increased need for revaccination has fueled the demand for conventional FMD vaccines. Also, increasing government funding has further paved the way for novel conventional FMD vaccines.

This report provides an accurate prediction of the contribution of all the segments to the growth of the foot and mouth disease vaccines market size and actionable market insights on post COVID-19 impact on each segment.

 

Foot And Mouth Disease Vaccines Market Scope
Report Coverage	Details
Page number	120
Base year	2020
Forecast period	2021-2025
Growth momentum & CAGR	Accelerate at a CAGR of 8.81%
Market growth 2021-2025	$ 1.08 billion
Market structure	Concentrated
YoY growth (%)	8.50
Regional analysis	Asia, Europe, North America, and ROW
Performing market contribution	Asia at 63%
Key consumer countries	China, South Korea (Republic of Korea), South Africa, Iran (Islamic Republic of Iran), and India
Competitive landscape	Leading companies, Competitive strategies, Consumer engagement scope
Key companies profiled	Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Indian Immunologicals Ltd., Inovio Pharmaceuticals Inc., LIMOR DE COLOMBIA SA , Merck & Co. Inc., SEPPIC SA, VECOL SA, and VETAL Animal Health Products Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Foot And Mouth Disease Vaccines Market Report?

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive foot and mouth disease vaccines market growth during the next five years
• Precise estimation of the foot and mouth disease vaccines market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the foot and mouth disease vaccines industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of foot and mouth disease vaccines market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch